Centre Asset Management, LLC Gilead Sciences, Inc. Transaction History

Centre Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 03, 2023	SELL	$77.31 - $88.08 $1.65 Million - $1.89 Million	-21,402 Reduced 17.43%	101,385 $8.41 Million
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $837,643 - $1.2 Million	-13,441 Reduced 9.87%	122,787 $10.5 Million
Q3 2022 Oct 04, 2022	SELL	$59.54 - $68.01 $46,441 - $53,047	-780 Reduced 0.57%	136,228 $8.4 Million
Q2 2022 Jul 06, 2022	BUY	$57.72 - $65.01 $7.91 Million - $8.91 Million	137,008 New	137,008 $8.47 Million
Q1 2022 Apr 13, 2022	SELL	$57.92 - $72.58 $2.18 Million - $2.73 Million	-37,649 Closed	0 $0
Q4 2021 Jan 11, 2022	BUY	$64.88 - $73.64 $2.44 Million - $2.77 Million	37,649 New	37,649 $2.73 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Centre Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Centre Asset Management, LLC with notifications on news.